共 291 条
- [1] Scher HI(2000)Clinical states in prostate cancer: toward a dynamic model of disease progression Urology 55 323-327
- [2] Heller G(2004)Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group J Clin Oncol 22 537-556
- [3] Scher HI(1999)Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1591-1597
- [4] Eisenberger M(2002)International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy J Clin Oncol 20 3206-3212
- [5] D'Amico AV(2000)Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 3352-3359
- [6] Halabi S(2001)Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer Urology 58 393-399
- [7] Small EJ(2003)Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer J Clin Oncol 21 4568-4571
- [8] Morris M(2006)Management of the patient with a rising PSA alone Hematol Oncol Clin North Am 20 897-908
- [9] Pound CR(2005)Rising prostate-specific antigen after primary prostate cancer therapy Nat Clin Pract Urol 2 174-182
- [10] Partin AW(2002)Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era Cancer 95 281-286